A
Arcturus Therapeutics Holdings Inc. (ARCT)
NGM – Real Time Price. Currency in USD
8.25
-0.39 (-4.46%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
8.25
-0.39 (-4.46%)
At close: May 12, 2026, 4:00 PM EDT
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Alan H. Cohen FAAAAI, FAAP, FACAAI, FCCP, M.D. | Chief Medical Officer |
| Dr. Igor Smolenov M.D., Ph.D. | Chief Development Officer |
| Dr. Padmanabh Chivukula Ph.D. | Founder, Chief Scientific Officer, COO & Secretary |
| Dr. Ye Zhang | Chief Regulatory & Quality Assurance Officer |
| Mr. Joseph Roberts | Principal Financial & Accounting Officer and Controller |
| Mr. Joseph E. Payne M.Sc. | Founder, President, CEO & Director |
| Mr. Kevin T. Skol | Chief Business Officer |
| Mr. Lance Kurata | Chief Legal Officer |
| Ms. Natasha O. Bowman | Chief Human Resources Officer |
| Ms. Neda Safarzadeh | Vice President and Head of IR/PR & Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | e665435_8k-arct.htm |
| 2026-05-07 | 10-Q | arct-20260331.htm |
| 2026-04-24 | DEF 14A | e665392_def14a-arct.htm |
| 2026-03-03 | 8-K | e665201_8k-arct.htm |
| 2026-03-03 | 10-K | arct-20251231.htm |
| 2025-12-30 | S-3 | e665045_s3-arct.htm |
| 2025-12-15 | 8-K | e665044_8k-arct.htm |
| 2025-11-12 | NT 10-Q | e664959_nt10q-arct.htm |
| 2025-11-10 | 8-K | e664953_8k-arct.htm |
| 2025-10-22 | 8-K | e664913_8k-arct.htm |